Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Centene Corp (NY: CNC )

60.37 +0.02 (+0.03%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Centene Corp

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Centene's First-Quarter Surge: Sales Soar To $40.41B, Exceeding Expectations: What's Next For The Healthcare Company?
Centene outperforms expectations with $40.41 billion in Q1 sales, driven by robust growth in premium revenues and steady membership. Raises full-year guidance amid strong momentum. 
Via Benzinga
3 Healthcare Stocks to Buy Now: Q2 Edition
Between an aging population and increased government spending, investors should consider these three healthcare stocks to buy now. 
Via InvestorPlace
Looking Into Centene's Recent Short Interest
Via Benzinga
Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
Investors remain on edge as geopolitics continue to shape market trends, with Israel mulling a response to Iran while the U.S. and key allies explore further sanctions against Tehran. 
Via Benzinga
Evaluating Centene: Insights From 7 Financial Analysts
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,700 Today
Via Benzinga
Despite its impressive fundamentals, NYSE:CNC remains undervalued.
CENTENE CORP (NYSE:CNC), an undervalued stock with good fundamentals. 
Via Chartmill
Wall Street Braces For Mixed Open As Middle-East Tensions Offset Earnings Optimism: Analyst Points To Silver Lining In Rally Break
Earnings optimism may partly offset worries concerning rising bond yields and the volatile geopolitical situation in the Middle East, with the index futures trading mixed early 
Via Benzinga
Topics Bonds
Exposures Debt Markets
See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina
Florida announces Medicaid contract awards to Centene, Elevance Health, and Humana, sidelining UnitedHealth, CVS Health, and Molina. Details on MMA and LTC services for over 3.4 million Floridians... 
Via Benzinga
Centene Jumps, Molina Slides With UNH Earnings On Tap
UnitedHealth earnings on Tuesday will offer an update on concerning medical utilization trends. Centene and Molina stocks are moving on Medicaid news. 
Via Investor's Business Daily
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
$1000 Invested In Centene 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Peering Into Centene's Recent Short Interest
Via Benzinga
UnitedHealth, Health Insurers Tumble On Medicare Advantage Rates
Final Medicare Advantage rates were unchanged vs. the initial proposal. 
Via Investor's Business Daily
Great Value Stocks To Buy Now
Here are three stocks that are trading at a great value based on their growth prospects and their current price. 
Via Talk Markets
Disney To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
5 Analysts Have This To Say About Centene
Via Benzinga
Despite its impressive fundamentals, NYSE:CNC remains undervalued.
Investors should take notice ofCENTENE CORP (NYSE:CNC)—it offers a great deal for the fundamentals it presents. 
Via Chartmill
Here's How Much You Would Have Made Owning Centene Stock In The Last 20 Years
Via Benzinga
Assessing Centene: Insights From 6 Financial Analysts
Via Benzinga
Here's How Much You Would Have Made Owning Centene Stock In The Last 10 Years
Via Benzinga
$1000 Invested In Centene 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Can UnitedHealth Group afford to keep Medicare Advantage plans?
UnitedHealth Group has, to date, been unaffected by the rising costs of Medicare Advantage; investors must decide if that shoe is yet to drop 
Via MarketBeat
Alphabet, Visa And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by around 0.2% on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Centene (CNC) Q4 2023 Earnings Call Transcript
CNC earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Crude Oil Gains 1%; Centene Sales Top Views
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 50 points on Tuesday. The Dow traded up 0.19% to 38,454.57 while the NASDAQ fell 0.41% to 15,534.23. The S&P... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Earnings Scheduled For February 6, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. 
Via Benzinga
Earnings Preview For Centene
Via Benzinga
Centene's Q4 Profits Reach $45M On Higher Membership, Premium As Enrollments Increase
Centene surpasses expectations with 11% Y/Y sales growth, reporting Q4 2023 revenue of $39.5 billion. Net profit rebounds to $45 million. Centene revises FY 2024 guidance. 
Via Benzinga
Highly Ranked Stocks To Watch As Earnings Approach
Set to release their quarterly results on Tuesday, February 6, here are several standout stocks that investors will certainly want to pay attention to. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.